Also in this experimental setting, TGF-β1 enhanced the protein expression of both markers as well as cilengitide was effective in counteract the TGF-β1 detrimental effect in both cell lines and able to downregulate the ανβ5 expression more efficiently in SHR-CF than in WKY-CF. Here, TGFB1 is linked to cystic fibrosis.